Cargando…
A methodological approach to correlate tumor heterogeneity with drug distribution profile in mass spectrometry imaging data
BACKGROUND: Drug mass spectrometry imaging (MSI) data contain knowledge about drug and several other molecular ions present in a biological sample. However, a proper approach to fully explore the potential of such type of data is still missing. Therefore, a computational pipeline that combines diffe...
Autores principales: | Prasad, Mridula, Postma, Geert, Franceschi, Pietro, Morosi, Lavinia, Giordano, Silvia, Falcetta, Francesca, Giavazzi, Raffaella, Davoli, Enrico, Buydens, Lutgarde M C, Jansen, Jeroen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688471/ https://www.ncbi.nlm.nih.gov/pubmed/33241286 http://dx.doi.org/10.1093/gigascience/giaa131 |
Ejemplares similares
-
Evaluation and comparison of unsupervised methods for the extraction of spatial patterns from mass spectrometry imaging data (MSI)
por: Prasad, Mridula, et al.
Publicado: (2022) -
Determination of Paclitaxel Distribution in Solid Tumors by Nano-Particle Assisted Laser Desorption Ionization Mass Spectrometry Imaging
por: Morosi, Lavinia, et al.
Publicado: (2013) -
Heterogeneity of paclitaxel distribution in different tumor models assessed by MALDI mass spectrometry imaging
por: Giordano, Silvia, et al.
Publicado: (2016) -
Quantitative determination of niraparib and olaparib tumor distribution by mass spectrometry imaging
por: Morosi, Lavinia, et al.
Publicado: (2020) -
3D Mass Spectrometry Imaging Reveals a Very Heterogeneous Drug Distribution in Tumors
por: Giordano, S., et al.
Publicado: (2016)